KALA News and Press, Kala Pharmaceuticals Inc. From 05/14/24

2024-05-14 17:05:24 ET More on Kala Pharmaceuticals Kala Pharmaceuticals GAAP EPS of -$3.18 beats by $0.44 Seeking Alpha’s Quant Rating on Kala Pharmaceuticals Historical earnings data for Kala Pharmaceuticals Financial information for Kala Pharmaceuti...

-- Patient enrollment ongoing in Phase 2b CHASE trial of KPI-012 for PCED; targeting topline data by year-end 2024 -- -- Evaluating opportunities to expand KPI-012 development into other corneal diseases, including LSCD and to explore KPI-014 in rare inherited retinal diseases -- ...

2024-04-12 19:12:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-04-03 08:15:04 ET H.C. Wainwright analyst issues BUY recommendation for KALA on April 3, 2024 06:43AM ET. The previous analyst recommendation was Buy. KALA was trading at $7.99 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current ...

2024-03-29 08:34:50 ET More on Kala Pharmaceuticals Seeking Alpha’s Quant Rating on Kala Pharmaceuticals Historical earnings data for Kala Pharmaceuticals Financial information for Kala Pharmaceuticals Read the full article on Seeking Alpha For...

-- Advancing ongoing Phase 2b CHASE trial of KPI-012 for PCED; topline data targeted by year-end 2024 -- -- Exploring opportunities to expand KPI-012 into additional corneal indications -- -- Cash resources as of December 31, 2023, together with proceeds from the March 2024 private pl...

China Resources Beer (Holdings) Company Limited ADR (CRHKY) is expected to report for Q4 2023 Melco International Development Ltd. (MDEVF) is expected to report for quarter end 2023-12-31 Meridian Mining UK Societas (MRRDF) is expected to report $0 for Q4 2023 BKF Capital Group Inc (B...

2024-03-23 20:02:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

Bitdeer Technologies Group (BTDR) is expected to report $0.11 for Q4 2023 BioForce Nanosciences Holdings Inc (BFNH) is expected to report for Q4 2023 Casino Guichard Perrachon ADR (CGUSY) is expected to report for quarter end 2023-12-31 Motorsport Games Inc. (MSGM) is expected to repo...

Tredegar Corporation (TG) is expected to report for quarter end 2023-12-31 Pharma-Bio Serv Inc (PBSV) is expected to report $0.02 for Q1 2024 Telos Corporation (TLS) is expected to report $-0.18 for Q4 2023 Coretec Group Inc (CRTG) is expected to report for quarter end 2023-12-31 ...